ALLMedicine™ Prostatic Hyperplasia Center
Research & Reviews 777 results
https://doi.org/10.1007/s11255-022-03220-6 10.1007/s11884-019-00566-z 10.1016/j.eururo.2004.12.010 10.1016/j.eururo.2008.03.099 10.1016/j.mcna.2017.11.001 10.5858/2000-124-1454-IPAAPP 10.1016/S0090-4295(03)00459-X 10.1016/j.ijsu.2020.05.025 10.1016/j.purol.2017.04.006 10.1007/s00345-018-2532-z 10.1007/s00345-014-1310-9 10.1016/j.urology.2015.06.002 10.1159/000492923 10.1007/s00345-018-2353-0 10.1007/s00345-017-2048-y 10.1056/NEJMoa1801993 10.1111/bju.15098
International Urology and Nephrology; Coman R, Anract J et. al.
May 11th, 2022 - After most surgical management of benign prostatic hyperplasia (BPH), the resected tissue undergoes a histological examination. This examination is performed for the risk of finding an incidental prostate cancer (iPCa). The improvement of prostate...
https://doi.org/10.1186/s12894-022-01014-7 10.1016/S0090-4295(02)02371-3 10.1007/s00345-020-03429-z 10.1111/luts.12394 10.1146/annurev-med-063014-123902 10.1002/nau.24616 10.1159/000511116 10.1016/j.eururo.2005.12.042 10.1586/erd.10.90 10.1111/j.1464-410X.2005.05253.x 10.1016/j.juro.2010.08.037 10.1016/j.urology.2014.06.025 10.21037/tau-19-780 10.1111/and.13807 10.1007/s00345-021-03769-4 10.4103/0970-1591.32061 10.1007/s00540-016-2256-4 10.1159/000348793 10.1159/000067979 10.1046/j.1464-410X.2002.03038.x 10.1089/end.2015.0506 10.1089/end.2011.0358
BMC Urology; Jin Q, Yang EG et. al.
Apr 21st, 2022 - To compare the intraoperative safety profiles of transurethral plasmakinetic resection of the prostate (PK-TURP) with transurethral plasmakinetic endoscopic enucleation of the prostate (PK-EEP) in the treatment of benign prostatic hyperplasia (BPH...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018703
Nature Communications; Vickman RE, Aaron-Brooks L et. al.
Apr 21st, 2022 - Autoimmune (AI) diseases can affect many organs; however, the prostate has not been considered to be a primary target of these systemic inflammatory processes. Here, we utilize medical record data, patient samples, and in vivo models to evaluate t...
https://doi.org/10.4111/icu.20210281
Investigative and Clinical Urology; Wei HB, Guo BY et. al.
Apr 20th, 2022 - The selection of open prostatectomy (OP) over transurethral laser surgery is controversial for large volume prostates. Thus, we aim to compare the efficacy and safety of transurethral laser versus OP, and provide the latest evidence of clinical pr...
https://doi.org/10.1002/jmri.28204
Journal of Magnetic Resonance Imaging : JMRI; Guo Z, Qin X et. al.
Apr 17th, 2022 - There is an overlap comparing transition zone prostate cancer (TZ PCa) and benign prostatic hyperplasia (BPH) on T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI), creating additional challenges for assessment of TZ tumors on MRI. To...
Guidelines 4 results
https://doi.org/10.1097/JU.0000000000002183
The Journal of Urology; Lerner LB, McVary KT et. al.
Aug 14th, 2021 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and severity of lower urinary tract symptoms (LUTS) in aging men are p...
https://doi.org/10.1097/JU.0000000000001298
The Journal of Urology; Parsons JK, Dahm P et. al.
Jul 24th, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...
https://doi.org/10.1097/JU.0000000000000319
The Journal of Urology; Foster HE, Dahm P et. al.
May 7th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778754
Investigative and Clinical Urology; Yeo JK, Choi H et. al.
Mar 12th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...
Drugs 378 results see all →
News 43 results
https://www.medscape.com/viewarticle/973554
May 9th, 2022 - NEW YORK (Reuters Health) - Aquablation appears to be a safe and effective for treatment for lower-urinary-tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), regardless of prostate volume, new data show. Aquablation using the AquaBea...
https://www.medscape.com/viewarticle/969720
Mar 7th, 2022 - NEW YORK (Reuters Health) - Rezum water vapor thermal therapy was safe and effective in patients with benign prostatic hyperplasia (BPH), in a registry study. "This prospectively collected registry of real-world cases shows Rezum to be a fast, eff...
https://www.medscape.com/viewarticle/969052
Feb 24th, 2022 - In the largest study of its kind, a series of 9-second shots with barely boiling water into enlarged prostates appears to be a safe and effective approach to treating benign prostatic hyperplasia (BPH), a Canadian-American team reported in the jou...
https://www.medscape.com/viewarticle/965388
Jan 20th, 2022 - This transcript has been edited for clarity. I'm Dr Neil Skolnik. Today, I'm going to talk about the American Urologic Association's new guidelines on the management of lower urinary tract symptoms, also called LUTS, due to benign prostatic hyperp...
https://www.medscape.com/viewarticle/957952
Sep 1st, 2021 - The American Urological Association (AUA) has updated its guidelines on managing male lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). The updates, the first since 2010, were summarized in the Journal of Urolog...
